Actively hiring
Process Manufacturing
Manufacturing
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$3.1M
1 round on record
Latest round
$3.1M
Venture round · Oct 2025 · 12 mo ago
Team
11-50
employees, estimated range
The money's age
Due for its next round
12 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2023
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2025 | $3.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Chirality Biosciences, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Arielle GabalskiExecutive Officer, DirectorSEC Form D
Joanna EagleExecutive OfficerSEC Form D
Overview
Chirality Biosciences is accelerating the course of humanity by building a world where life-saving drugs don’t come with a lifetime of compromises. We’re a pharmaceutical manufacturing company building next-generation chiral separation technology.
People

Arielle Gabalski
Executive Officer, Director

Joanna Eagle
Executive Officer

Robert Kayton
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Farmingdale
United States
HQ
10-50 est. staff
Financials
Total raised
$3.1M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | $3.1M | Details |
